ST. MARYS OF MICHIGAN
The Sunshine Act requires manufacturers to report payments to teaching hospitals as institutions, separately from payments to individual physicians. These figures are money reported to the hospital itself — most of it research funding and grants, not compensation to any named doctor.
- Total reported
- $1.4M
- Transactions
- 518
- Companies
- 23
- Average per transaction
- $2,664
Who reported the payments
| Novartis | $866,434 |
| Esperion Therapeutics, Inc. | $132,959 |
| Edwards Lifesciences | $86,608 |
| AstraZeneca | $64,044 |
| Boston Scientific | $63,431 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | $35,691 |
| Astrazeneca UK Limited | $31,335 |
| CSL Behring | $31,064 |
| Bio-rad Laboratories, Inc. | $20,164 |
| Merck | $9,832 |
| Abbott | $6,279 |
| Medical Device Business Services, Inc. | $6,000 |
| Cvrx, Inc. | $5,739 |
| Pentax Of America, Inc. | $5,268 |
| Aesculap Implant Systems, LLC | $4,915 |
| Biotronik Inc. | $3,995 |
| Stryker | $2,309 |
| Amgen | $1,250 |
| Aesculap, Inc. | $1,179 |
| Zimmer Biomet | $585 |
| ZOLL Medical Corporation | $500 |
| Siemens Medical Solutions USA, Inc. | $421 |
| Biofire Diagnostics, LLC | $173 |